Vivaldi Biosciences
Developing nasal-spray, self-adjuvanting vaccines: DeltaFLU universal flu vaccine, and Delta-19 universal flu + Covid-19
11 employees · est. 2006 · Fort Collins, United States
Vivaldi Biosciences is the older company (2017 vs 2006); Osivax is the larger of the two.
Side-by-Side Comparison
| Metric | Osivax | Vivaldi Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2006 older |
| Headquarters | ||
| Headquarters | Lyon, France | Fort Collins, United States |
| Employees | ||
| Employees | 53 larger | 11 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | Grant | Series Unknown |
| Total Funding | ||
| Total Funding | $53.30M | $26.97M |
| Funding Rounds | ||
| Funding Rounds | 7 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Immunology, Vaccine, Infectious Diseases, Pan-respiratory Virus, Cellular Immune Response, CD8 T-cell, Immuno-oncology, Nanoparticle Platform Technology, Clinical-stage Biopharmaceutical Company, Universal Vaccines, Ovx836, OligODOM, Sarbocovirus, Clinical Trials | Not tracked yet |
| Website | ||
| Website | osivax.com | vivaldibiosciences.com |
About Osivax
Osivax is a clinical-stage biopharmaceutical company founded in 2017, with its headquarters in France. The company is pioneering a new class of universal vaccines utilizing the oligoDOM® nanoparticle platform technology. Their flagship product, OVX836, a broad-spectrum "universal" influenza candidat...
About Vivaldi Biosciences
Vivaldi Biosciences is a biotechnology company that was founded in 2006. The company received a $1.97M Venture Round investment on 08 July 2010. This investment marked a significant milestone for the company and served to propel its growth and development within the biotechnology industry. As the co...
We will tell you when either one moves
BounceWatch watches Osivax and Vivaldi Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Osivax and Vivaldi Biosciences — by email.
Frequently Asked Questions
Compare Osivax with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Osivax on 11 Sep 2024, and Vivaldi Biosciences on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.